Cross-Border M&A in 2025: Lessons from $130B Deals Reshaping Chemical, Biotech, and Mid-Market Private Equity
The $130 billion DuPont–Dow merger and a surge of cross-border acquisitions in biotech, private equity, and digital are redefining how M&A is structured and executed globally. Decision-makers must align due diligence, post-merger integration, and regulatory strategy from day one to capture deal value.